Synergistic chromatin repression of the tumor suppressor gene RARB in human prostate cancers

Epigenetics

Volumn 9, Issue 4, 2014, Pages 477-482

  Moison, Céline ^a,b,c,d   Assemat, Fanny ^a   Daunay, Antoine ^e   Tost, Jörg ^e,f   Guieysse Peugeot, Anne Laure ^b,c   Arimondo, Paola B ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^c INSER M U872   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e CEPS   (France)

^f CENTRE NATIONAL DE GÉNOTYPAGE   (France)

Author keywords

DNA hypermethylation; EZH2; H3K27 trimethylation; Polycomb protein; Prostate cancer; Retinoic acid receptor beta (RAR )

Indexed keywords

POLYCOMB GROUP PROTEIN; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR BETA 2; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG; CHROMATIN; HISTONE; RETINOIC ACID RECEPTOR;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; PROSTATE CANCER; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; CHROMATIN; CPG ISLAND; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROMOTER REGION; PROSTATE TUMOR; TUMOR SUPPRESSOR GENE;

AGED; CHROMATIN; CPG ISLANDS; DNA METHYLATION; GENES, TUMOR SUPPRESSOR; HISTONES; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, RETINOIC ACID;

EID: 84899143567     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.27869     Document Type: Article

References (30)

1. Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, Yamochi T, Urano T, Furukawa K, Kwabi-Addo B, et al. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 2008; 40:741-50; PMID:18488029; http://dx.doi.org/10.1038/ng.159
2. Lindroth AM, Park YJ, McLean CM, Dokshin GA, Persson JM, Herman H, Pasini D, Miró X, Donohoe ME, Lee JT, et al. Antagonism between DNA and H3K27 methylation at the imprinted Rasgrf1 locus. PLoS Genet 2008; 4:e1000145; PMID:18670629; http://dx.doi.org/10.1371/journal.pgen.1000145
3. Takeshima H, Yamashita S, Shimazu T, Niwa T, Ushijima T. The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands. Genome Res 2009; 19:1974-82; PMID:19652013; http://dx.doi.org/10.1101/ gr.093310.109
4. Brinkman AB, Gu H, Bartels SJ, Zhang Y, Matarese F, Simmer F, Marks H, Bock C, Gnirke A, Meissner A, et al. Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk. Genome Res 2012; 22:1128-38; PMID:22466170; http://dx.doi. org/10.1101/gr.133728.111
5. Statham AL, Robinson MD, Song JZ, Coolen MW, Stirzaker C, Clark SJ. Bisulfite sequencing of chromatin immunoprecipitated DNA (BisChIP-seq) directly informs methylation status of histone-modified DNA. Genome Res 2012; 22:1120-7; PMID:22466171; http://dx.doi.org/10.1101/gr.132076.111
6. Moison C, Senamaud-Beaufort C, Fourrière L, Champion C, Ceccaldi A, Lacomme S, Daunay A, Tost J, Arimondo PB, Guieysse-Peugeot AL. DNA methylation associated with polycomb repression in retinoic acid receptor β silencing. FASEB J 2013; 27:1468-78; PMID:23299856; http://dx.doi. org/10.1096/fj.12-210971
7. Houle B, Rochette-Egly C, Bradley WE. Tumorsuppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. Proc Natl Acad Sci U S A 1993; 90:985-9; PMID:8381540; http:// dx.doi.org/10.1073/pnas.90.3.985
8. Seewaldt VL, Johnson BS, Parker MB, Collins SJ, Swisshelm K. Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ 1995; 6:1077-88; PMID:8519684
9. Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, Mohammad HP, Chen W, Daniel VC, Yu W, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007; 39:237-42; PMID:17211412; http://dx.doi. org/10.1038/ng1972
10. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, Eden E, Yakhini Z, Ben-Shushan E, Reubinoff BE, et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 2007; 39:232-6; PMID:17200670; http://dx.doi. org/10.1038/ng1950
11. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, Weisenberger DJ, Campan M, Young J, Jacobs I, et al. Epigenetic stem cell signature in cancer. Nat Genet 2007; 39:157-8; PMID:17200673; http://dx.doi.org/10.1038/ng1941
12. Viré E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, Morey L, Van Eynde A, Bernard D, Vanderwinden JM, et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006; 439:871-4; PMID:16357870; http:// dx.doi.org/10.1038/nature04431
13. Mohammad HP, Cai Y, McGarvey KM, Easwaran H, Van Neste L, Ohm JE, O'Hagan HM, Baylin SB. Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation. Cancer Res 2009; 69:6322-30; PMID:19602592; http://dx.doi. org/10.1158/0008-5472.CAN-09-0065
14. Cho NY, Kim BH, Choi M, Yoo EJ, Moon KC, Cho YM, Kim D, Kang GH. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features. J Pathol 2007; 211:269-77; PMID:17139617; http://dx.doi. org/10.1002/path.2106
15. Bovenzi V, Lê NL, Côte S, Sinnett D, Momparler LF, Momparler RL. DNA methylation of retinoic acid receptor beta in breast cancer and possible therapeutic role of 5-aza-2′-deoxycytidine. Anticancer Drugs 1999; 10:471-6; PMID:10477167; http://dx.doi. org/10.1097/00001813-199906000-00007
16. Sirchia SM, Ferguson AT, Sironi E, Subramanyan S, Orlandi R, Sukumar S, Sacchi N. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells. Oncogene 2000; 19:1556-63; PMID:10734315; http://dx.doi.org/10.1038/sj.onc.1203456
17. Widschwendter M, Berger J, Hermann M, Müller HM, Amberger A, Zeschnigk M, Widschwendter A, Abendstein B, Zeimet AG, Daxenbichler G, et al. Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. J Natl Cancer Inst 2000; 92:826-32; PMID:10814678; http://dx.doi. org/10.1093/jnci/92.10.826
18. Antequera F, Boyes J, Bird A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 1990; 62:503-14; PMID:1974172; http://dx.doi. org/10.1016/0092-8674(90)90015-7
19. Ke XS, Qu Y, Cheng Y, Li WC, Rotter V, Øyan AM, Kalland KH. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells. BMC Genomics 2010; 11:669; PMID:21108828; http://dx.doi. org/10.1186/1471-2164-11-669
20. Ke XS, Li WC, Hovland R, Qu Y, Liu RH, McCormack E, Thorsen F, Olsen JR, Molven A, Kogan-Sakin I, et al. Reprogramming of cell junction modules during stepwise epithelial to mesenchymal transition and accumulation of malignant features in vitro in a prostate cell model. Exp Cell Res 2011; 317:234-47; PMID:20969863; http://dx.doi. org/10.1016/j.yexcr.2010.10.009
21. Kirmizis A, Bartley SM, Kuzmichev A, Margueron R, Reinberg D, Green R, Farnham PJ. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev 2004; 18:1592-605; PMID:15231737; http://dx.doi. org/10.1101/gad.1200204
22. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 2006; 20:1123-36; PMID:16618801; http://dx.doi. org/10.1101/gad.381706
23. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002; 419:624-9; PMID:12374981; http://dx.doi.org/10.1038/nature01075
24. Moison C, Arimondo PB, Guieysse-Peugeot AL. Commercial reverse transcriptase as source of falsepositive strand-specific RNA detection in human cells. Biochimie 2011; 93:1731-7; PMID:21689721; http://dx.doi.org/10.1016/j.biochi.2011.06.005
25. Zhao J, Ohsumi TK, Kung JT, Ogawa Y, Grau DJ, Sarma K, Song JJ, Kingston RE, Borowsky M, Lee JT. Genome-wide identification of polycomb-associated RNAs by RIP-seq. Mol Cell 2010; 40:939-53; PMID:21172659; http://dx.doi.org/10.1016/j. molcel.2010.12.011
26. Gal-Yam EN, Egger G, Iniguez L, Holster H, Einarsson S, Zhang X, Lin JC, Liang G, Jones PA, Tanay A. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc Natl Acad Sci U S A 2008; 105:12979-84; PMID:18753622; http://dx.doi. org/10.1073/pnas.0806437105
27. Wu H, Coskun V, Tao J, Xie W, Ge W, Yoshikawa K, Li E, Zhang Y, Sun YE. Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes. Science 2010; 329:444-8; PMID:20651149; http://dx.doi.org/10.1126/ science.1190485
28. Reddington JP, Perricone SM, Nestor CE, Reichmann J, Youngson NA, Suzuki M, Reinhardt D, Dunican DS, Prendergast JG, Mjoseng H, et al. Redistribution of H3K27me3 upon DNA hypomethylation results in de-repression of Polycomb target genes. Genome Biol 2013; 14:R25; PMID:23531360; http://dx.doi. org/10.1186/gb-2013-14-3-r25
29. Reddington JP, Sproul D, Meehan RR. DNA methylation reprogramming in cancer: Does it act by re-configuring the binding landscape of Polycomb repressive complexes? Bioessays 2014; 36:134-40; PMID:24277643; http://dx.doi.org/10.1002/ bies.201300130
30. Tost J, Gut IG. DNA methylation analysis by pyrosequencing. Nat Protoc 2007; 2:2265-75; PMID:17853883; http://dx.doi.org/10.1038/ nprot.2007.314